Liposome Co Inc at its annual
meeting announced the formation of a Canadian subsidiary,
Canadian Liposome Co Ltd.
    It said the company cements a relationship with University
of British Columbia researcher Pieter Cullis and his scientific
group who are developing anti-cancer products for Liposome.
    The company also said lead bankers completed Liposome's
stock offering of one mln shares on June 11 at 6.875 dlrs a
share. Liposome said it netted 7,388,750 dlrs.
 Reuter
&#3;